Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore

Glioblastoma (GBM) is the most common primary malignant tumor of the central nervous system with a dismal prognosis. Locoregional failure is common despite high doses of radiation therapy, which has prompted great interest in developing novel strategies to radiosensitize these cancers. Our group pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Paradkar, Sateja, Herrington, James, Hendricson, Adam, Hewawasam, Piyasena, Plummer, Mark, Hoyer, Denton, Sundaram, Ranjini K., Surovtseva, Yulia V., Bindra, Ranjit S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092340/
https://www.ncbi.nlm.nih.gov/pubmed/33953843
http://dx.doi.org/10.18632/oncotarget.27933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092340/
https://www.ncbi.nlm.nih.gov/pubmed/33953843
http://dx.doi.org/10.18632/oncotarget.27933

Ejemplares similares